COYA: Rega marang dodolan Coya

Logo korporat perusahaan Coya (COYA)

Coya Therapeutics, Inc. (COYA) develops cellular therapies for neuropathologies, leveraging robust cold chains and diversified manufacturing facilities. The price-to-sales ratio reflects market expectations, where the 15.60 indicator expresses the state of the metric. Despite the risks of component logistics disruptions due to global conflicts, the humanitarian status of developments in the US ensures research stability and protection from sanctions.

COYA: Multiplikator P/S coyatherapeutics.com 21.03.2024 - 16.11.2026

Rincian analitis perusahaan Coya Therapeutics, Inc. (COYA)

Ringkesan analitik perusahaan:COYA coyatherapeutics.com
Barang unggulan Coya

The stability of Coya Therapeutics, Inc. (COYA) relies on partner co-financing for the development of drugs targeting ALS and Alzheimer's disease. The P/S ratio relates market capitalization to annual sales volume, measuring the premium investors place on current revenue. By analyzing the company's P/S level, one can identify whether the asset is undervalued or if there is a risk of inflated expectations regarding clinical scaling. This metric allows for the determination of the business's fair value during the early growth stage.

Karo sapa Coya Therapeutics, Inc. saingan

BIIB (Biogen) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NBIX (Neurocrine Corp)|Regencell Bioscience - Rasio rega marang pendapatan|Axsome Therapeutics - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Rasio rega marang pendapatan|Rega marang dodolan Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - Multiplikator P/S|CPRX: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S DNLI|Koefisien rega marang pendapatan Harmony Biosciences|Biohaven Ltd - Kapitalisasi marang pendapatan|Multiplikator P/S Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Praxis Corp PRAX|AVXL: Multiplikator P/S|CBLL (ceribell.com) - Rasio rega marang pendapatan|PRTA (Prothena Corporation) - Multiplikator P/S|Kapitalisasi marang pendapatan alector.com (ALEC)|Rasio rega marang pendapatan Annexon, Inc. (ANNX)|OMER - Rega marang dodolan|Multiplikator P/S NGNE (Neurogene Inc)|AC Immune (ACIU) - Rega marang dodolan|Voyager Therapeutics Inc - Multiplikator P/S|Neumora (NMRA) - Kapitalisasi marang pendapatan|SCLX: Multiplikator P/S|TVGN - Koefisien rega marang pendapatan|ACOG (Alpha Cognition Inc) - Multiplikator P/S|Kapitalisasi marang pendapatan cogrx.com (CGTX)|Rasio rega marang pendapatan Inhibikase Therapeutics Inc (IKT)|Koefisien rega marang pendapatan Cassava Sciences|Multiplikator P/S ASRT (Assertio Holdings)|Kapitalisasi marang volume dodolan VTGN (VistaGen Therapeutics Inc)|OVID: Kapitalisasi marang pendapatan|ABOS: Rasio rega marang pendapatan|CervoMed (CRVO) - Rasio rega marang pendapatan|Rega marang dodolan Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan PEPG (PepGen)|Kapitalisasi marang pendapatan JUNS (Jupiter Neurosciences, Inc.)|Multiplikator P/S relmada.com (RLMD)|Rasio rega marang pendapatan Annovis Bio Corp ANVS|GRCE: Rasio kapitalisasi marang pendapatan|AIFF - Rasio rega marang pendapatan|KLTO (anewmeds.com) - Rasio kapitalisasi marang pendapatan|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalisasi marang pendapatan|revivapharma.com - Rasio kapitalisasi pasar marang pendapatan|MTVA (metaviatx.com) - Multiplikator P/S|NRXS: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S HSDT|PASG - Rega marang dodolan|Multiplikator P/S NEUP (Neuphoria Therapeutics)|NERV: Rasio kapitalisasi marang pendapatan|ATHA: Kapitalisasi marang pendapatan|Addex Therapeutics Ltd - Kapitalisasi marang volume dodolan|Alzamend Neuro, Inc. (ALZN) - Rasio rega marang pendapatan|CYCN (Cyclerion Therapeutics Inc.) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan PTIX|KTTA: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Brainstorm Cell Therapeutics, Inc. BCLI|Rasio kapitalisasi pasar marang pendapatan CARA|chromocell.com - Multiplikator P/S|Rasio rega marang dodolan ELYM|ITCI: Multiplikator P/S|Rega marang dodolan Longboard Pharmaceuticals, Inc. (LBPH)|Rasio rega marang pendapatan Marinus Pharmaceuticals, Inc.|NKGN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NRBO|SAGE: Rasio rega marang dodolan|Synaptogenix Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - Multiplikator P/S|Anew Medical (WENA) - Kapitalisasi marang pendapatan|CERE (Cerevel Corp) - Kapitalisasi marang pendapatan